DeutschNewstral
Article
Bbarrons.com on 2021-07-14 17:26
Roche Stock Could Be an Alzheimer's Winner3 min read
Related news
- BRoche Sinks as Alzheimer's Drug Disappoints. Biogen is Gaining. 1 min readbarrons.com
- BBiogen Stock Can Go 'Decisively Higher' on Sales of Alzheimer's Drug2 min readbarrons.com
- MEurope stocks head for a fresh record close, led by Roche and oil giants3 min readmarketwatch.com
- BHow Sage Therapeutics Beaten-Down Stock Could Come Back2 min readbarrons.com
- MRoche says Phase 3 studies for Alzheimer's drug failed to meet primary endpoints1 min readmarketwatch.com
- BThe $56,000 Price of Biogen's Alzheimer's Drug Could Backfire4 minbarrons.com
- BEli Lilly Stock Soared on Alzheimer's Hopes. Now Wall Street Has Doubts.3 min readbarrons.com
- BBiogen Stock Is Tumbling Because Its Alzheimer's Drug Rollout Isn't Going So Well2 min readbarrons.com
- BBiogen Stock Tumbles After EU Regulator Has Doubts on Controversial Alzheimer's Therapy1 min readbarrons.com
- BStreet Shrugs Off FDA's Call for Probe of Alzheimer's Drug Approval3 min readbarrons.com
- BFDA Narrows Its Label on Biogen's Alzheimer's Drug a Month After Approving It3 min readbarrons.com
- BAnalyst Raises Price Targets on 3 Smaller Alzheimer's Stocks2 min readbarrons.com
- BNovartis to Spend Bulk of Roche Windfall on Buying Back Stock, Not M&A3 min readbarrons.com
- BAcknowledging Concerns Over Biogen's Alzheimer's Drug, FDA Asks for Investigation2 min readbarrons.com
- BRoche's Failed Alzheimer's Trial Could Have Implications for Lilly, Biogen3 min readbarrons.com
- BBiogen in Pole Position After Roche's Alzheimer's Drug Disappoints3 min readbarrons.com
- MBiogen and Eisai make plans to take another Alzheimer's drug to the FDA3 min readmarketwatch.com
- BPayPal Stock Could Have More Risk Than Reward2 min readbarrons.com
- BHow Nintendo's Beaten-Down Stock Could Turn Around2 min readbarrons.com
- BBiogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says2 min readbarrons.com